Insulin Lispro

Insulin lispro, the active ingredient in Insulin Lispro, is a rapid-acting insulin analog presented as an injectable solution for subcutaneous use. It treats elevated blood glucose in people with type 1 and type 2 diabetes. GNH USA supplies Insulin Lispro as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.

Type 1 diabetes mellitus: provides mealtime glucose control and reduces post‑prandial spikes. Type 2 diabetes mellitus: used as part of intensive insulin regimens to improve post‑prandial glycaemia.

Insulin lispro may cause a range of adverse reactions.

Common Side Effects: - Hypoglycemia: low blood glucose episodes, especially if meals are missed or dosing is excessive. - Injection site pain or erythema: mild discomfort at the injection site. - Lipodystrophy: localized changes in subcutaneous fat with repeated injections. - Weight gain: modest increase associated with improved glycaemic control. - Mild allergic reactions: localized itching or rash.

Serious or Rare Side Effects: - Severe hypoglycemia: neurological impairment requiring assistance. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Hypokalemia: low serum potassium levels, particularly with high insulin doses. - Edema: fluid retention, especially in patients with cardiac or renal disease. - Serum sickness‑like reaction: fever, arthralgia, and rash.

When using Insulin lispro, consider the following precautions.

Dose adjustment: tailor the dose based on frequent blood‑glucose monitoring and meal patterns. Renal impairment: monitor closely as reduced clearance may increase hypoglycemia risk. Pregnancy: use only if the anticipated benefit justifies potential risk to the fetus. Alcohol consumption: may potentiate hypoglycemia; advise patients to limit intake. Driving or operating machinery: ensure glucose is within safe range before engaging in such activities. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro can interact with several medications, requiring vigilance.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms, delaying recognition. - Monoamine oxidase inhibitors (MAOIs): can potentiate insulin’s glucose‑lowering effect. - Alcohol: enhances risk of severe hypoglycemia, especially with rapid‑acting insulins.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may increase blood glucose, necessitating dose adjustments. - Corticosteroids: can raise glucose levels, potentially requiring higher insulin doses. - Oral contraceptives: may alter insulin requirements, warranting closer monitoring.